Chantal Roshetar

Communications Associate Vice President @cityofhope Opinions are my own.

[Chantal Roshetar @ChantalR]

Come on, let's vote for this innovative first in human CAR T trial! This is all for fun, friendly competition and Baylor is currently beating us with a mouse study :) For this round, you can vote 5 times! #STATMadness2025
@TDorffOnc
@SaulPriceman
@elizabeth_budde
@montypal

[City of Hope @cityofhope]

#STATMadness continues!

Our @cityofhope team (feat. @TDorffOnc's research titled "CAR-T therapy for prostate cancer") has advanced to round 2 of the bracket-style competition and we need your votes!

Up to 5 votes per person allowed: https://t.co/9ESYZBfYQ4 #STATMadness2025

[Chantal Roshetar @ChantalR]

@a_silverstein Great to see you!

[City of Hope @cityofhope]

In this @NPR feature, learn about a groundbreaking treatment giving hope to patients like DeShawn Chow, a 19-year-old battling sickle cell disease at City of Hope Children's Cancer Center. https://t.co/BDWxyhAnUj

[Chantal Roshetar @ChantalR]

So happy to be back in person for this inspiring event

[City of Hope @cityofhope]

What an incredible day! On May 3, over 4,000 blood cancer survivors gathered to celebrate our 48th annual BMT reunion. Thank you to everyone who joined us to make this day so special. Read more: https://t.co/OsWGXokZga

[Chantal Roshetar @ChantalR]

A convergence of glioblastoma CAR T publications including @CityofHope, Harvard and Penn: https://t.co/2qHKTz6SA9

[Chantal Roshetar @ChantalR]

Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi https://t.co/372RLIxS0a via @statnews

[Chantal Roshetar @ChantalR]

What a great #ASH23 so far!

[City of Hope @cityofhope]

City of Hope will be at #ASH23! Our doctors and scientists will deliver their latest research, including a late-breaking abstract presented by Ibrahim Aldoss, M.D., on Monday, December 11.

Learn more: https://t.co/sA1ZXzC5BI

[STAT @statnews]

The FDA has approved the world’s first medicine based on #CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease. 🧵 https://t.co/01YGdXybX8

[Chantal Roshetar @ChantalR]

Such an honor to work closely with Dr. Carpten and thank you to Paul Goldberg @cancerletter for capturing some of his vision for @cityofhope

[The Cancer Letter @TheCancerLetter]

.@cityofhope's John Carpten: "In America, opportunities have not been provided or made available equitably. That history can’t simply be forgotten...I've always come from the standpoint that there’s no reason to separate excellence from diversity.”
https://t.co/E4HPL8LVu7

[Chantal Roshetar @ChantalR]

Chuck E. Cheese is getting rid of its animatronic bands, except here…it’s not our beloved neighborhood locale https://t.co/21PulCcDQk

[Chantal Roshetar @ChantalR]

Well deserved and honored to work with this amazing leader

[City of Hope @cityofhope]

John D. Carpten, Ph.D., chief scientific officer, the Irell & Manella Cancer Center Director's Distinguished Chair and Morgan & Helen Chu Director's Chair of the Beckman Research Institute has been elected to @theNAMedicine. Read: https://t.co/Ok0GQasq4n #NAMmtg

[Chantal Roshetar @ChantalR]

How Epic took over the hospital EHR market https://t.co/dq41OE9kAg via @modrnhealthcr

[Chantal Roshetar @ChantalR]

Saw #Starlink while on a walk just now! @SpaceX

[Chantal Roshetar @ChantalR]

A Third-Generation French Baker Opens LA’s Newest Croissant Contender in Pasadena https://t.co/Nghjaw0ZHe via @EaterLA

[Matthew Herper @matthewherper]

Anyone paying attention in medicine has been hearing a lot about obesity drugs. Same for Alzheimer's.

Here's a question: how is it that one company, Eli Lilly, ended up being in pole position in both diseases?

I went digging and found a buddy movie.
https://t.co/fVNYzq71rc

[Chantal Roshetar @ChantalR]

@chimoose @Twitter @HealthQuant @Doctor_V @drdonsdizon @mtmdphd @AnkurKalraMD @mmamas1973 @DrHarryThomas @RichDuszak Anecdotally, the only people I see leaving are people like us (non-HCPs), and inversely feel like I'm seeing more HCP interest

[Amanda Salas @AmandaSalas]

June is National Cancer Survivor Month, and I need your help! I am looking to feature videos from cancer survivors! Send a 10-15 second video sharing words of hope for those still in the fight! Please email these videos to: [email protected]
Subject: Cancer Survivor video
🫶🏼

[Sumanta K. Pal, MD, FASCO @montypal]

Flawless presentation by @DrChoueiri at #ASCO23 of #CONTACT03 results. We didn’t sleep much over the past several weeks putting this manuscript together for simultaneous pub in @TheLancet! Thank you to @katy_beckermann & @brian_rini for a terrific editorial accompanying the piece. Clearly, we need prospective data (across tumor types!) before we re-challenge w IO. Thank you to @NehaVapiwala & the @ASCO committee for highlighting our work!

[Chantal Roshetar @ChantalR]

One of our most exciting pieces of data this year...plenary, press briefing #ASCO23

[City of Hope @cityofhope]

Alex Herrera, M.D., discusses the results from a @SWOG Phase 3 study that compared nivolumab-AVD and brentuximab vedotin-AVD in patients with Stage 3 or 4 classic Hodgkin lymphoma. #ASCO23

[City of Hope @cityofhope]

City of Hope is proud to join #CancerX as a founding member to unleash the power of innovation in the fight against #cancer as part of the #CancerMoonshot initiative. More: https://t.co/SFrsmJ4vq2